Zidovudine Treatment Results in the Selection of Human Immunodeficiency Virus Type 1 Variants Whose Genotypes Confer Increasing Levels of Drug Resistance

Journal of General Virology - United Kingdom
doi 10.1099/0022-1317-75-2-341
Full Text
Abstract

Available in full text

Categories
Virology
Date
Authors
Publisher

Microbiology Society

Related search

Nonisotopic Hybridization Assay for Determination of Relative Amounts of Genotypic Human Immunodeficiency Virus Type 1 Zidovudine Resistance.

Journal of Clinical Microbiology
Microbiology
1995English

Combination Treatment With Zidovudine, Didanosine, and Nevirapine in Infants With Human Immunodeficiency Virus Type 1 Infection

New England Journal of Medicine
Medicine
1997English

"Resistance" to PSC-RANTES Revisited: Two Mutations in Human Immunodeficiency Virus Type 1 HIV-1SF162 or Simian-Human Immunodeficiency Virus SHIVSF162-p3 Do Not Confer Resistance

Journal of Virology
Insect ScienceImmunologyMicrobiologyVirology
2010English

Screening for Antiretroviral Drug Resistance Among Treatment-Naive Human Immunodeficiency Virus Type 1-Infected Individuals in Lebanon

Journal of Infection in Developing Countries
MedicineVirologyParasitologyInfectious DiseasesMicrobiology
2014English

Evaluation of Dried Blood Spots for Human Immunodeficiency Virus Type 1 Drug Resistance Testing

Journal of Clinical Microbiology
Microbiology
2006English

BI-RG-587 Is Active Against Zidovudine-Resistant Human Immunodeficiency Virus Type 1 and Synergistic With Zidovudine.

Antimicrobial Agents and Chemotherapy
Infectious DiseasesPharmacology
1991English

Correlation Between Viral Resistance to Zidovudine and Resistance at the Reverse Transcriptase Level for a Panel of Human Immunodeficiency Virus Type 1 Mutants

Journal of Virology
Insect ScienceImmunologyMicrobiologyVirology
2001English

Natural Variation of Drug Susceptibility in Wild-Type Human Immunodeficiency Virus Type 1

Antimicrobial Agents and Chemotherapy
Infectious DiseasesPharmacology
2004English

Cross-Resistance Analysis of Human Immunodeficiency Virus Type 1 Variants Individually Selected for Resistance to Five Different Protease Inhibitors

Antimicrobial Agents and Chemotherapy
Infectious DiseasesPharmacology
1995English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy